Saturday, November 4, 2017

Transcription

1 Program as of please use only the Interactive program for the most updated version. Saturday, November 4, 2017 ORAL COMMUNICATION: BEST ORAL PRESENTATIONS 01 09:30-10:30 HALL A Chair: David Cibula (Czech Republic) Chair: Heinz Koelbl (Austria) 09:30 TBC : TBC TBC () 09:45 AGO-OVAR 12: A RANDOMIZED PLACEBO-CONTROLLED GCIG/ENGOT- INTERGROUP PHASE III TRIAL WITH CHEMOTHERAPY +/- NINTEDANIB FOR ADVANCED OVARIAN CANCER: OVERALL SURVIVAL RESULTS : Isabelle Ray-Coquard (France) 10:00 CISPLATIN CHEMO-RADIATION VERSUS RADIATION IN FIGO STAGE IIIB SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX (CRACX TRIAL: NCT ) : Umesh Mahantshetty (India) 10:15 CHANGES IN NEOANGIOGENETIC PROFILE OF PAIRED PRIMARY AND RECURRENT HIGH-GRADE SEROUS OVARIAN CANCER (HGOSC): A STUDY OF THE OCTIPS CONSORTIUM. : Ilary Ruscito (Italy) PATIENTS PROGRAM: PATIENTS PROGRAM 1 10:00-17:00 HALL N 10:00 PATIENT SEMINAR WELCOME REMARKS - ESGO PRESIDENT David Cibula (Czech Republic) 10:04 PATIENT SEMINAR WELCOME REMARKS - ENGAGE CO-CHAIR Murat Gultekin (Turkey) 10:08 PATIENT SEMINAR WELCOME REMARKS -- ENGAGE CO-CHAIR Esra Urkmez (Turkey)

2 10:12 PATIENT SEMINAR WELCOME REMARKS - PATIENT SEMINAR CO-CHAIR Dina Kurdiani (Georgia) 10:15 COFFEE BREAK, MEET AND GREET 10:30 ROUNDTABLE DISCUSSIONS - WHAT IS NEW IN GYNAECOLOGICAL CANCERS? 10:31 TABLE 1 - OVARIAN CANCER Jonathan Ledermann (United Kingdom) 10:31 TABLE 2 - CERVICAL CANCER Francesco Raspagliesi (Italy) 10:31 TABLE 3 - VULVAR & VAGINAL CANCER Sven Mahner (Germany) 10:31 TABLE 4 - UTERINE CANCER Carien Creutzberg (The Netherlands) 12:00 LUNCH BREAK 13:00 BLOCK 1 Chair: Cristiana Sessa (Switzerland) Chair: Birthe Lemley (Denmark) 13:01 WHAT IS A CLINICAL TRIAL? - DEVELOPMENT OF A NEW DRUG/NEW TREATMENT Cristiana Sessa (Switzerland) 13:15 WHAT IS A CLINICAL TRIAL? - DEVELOPMENT OF A NEW DRUG/NEW TREATMENT Birthe Lemley (Denmark) 13:30 DISCUSSION 13:35 MANAGEMENT OF SURVIVORSHIP, ROLE OF REPEATED CONTROLS AND REHABILITATION Heidi Donovan (USA) 14:05 HPV VACCINATION & SCREENING - WHAT IS IT, WHY IT IS IMPORTANT - HEALTH PROFESSIONALS VOICE, NGO S VOICE, PATIENT S VOICE. 14:06 CERVICAL CANCER SCREENING WITH HPV DNA: UP TO DATE INFO FROM EUROPE Murat Gultekin (Turkey) 14:20 HPV VACCINATION AND FUTURE OF CERVICAL CANCER IN EUROPE Xavier Bosch (Spain) 14:35 WHY WE CAN? WHY WE CANNOT? ENGAGE PERSPECTIVE Maude Anderssen (Sweden) 14:50 DISCUSSION 15:05 COFFEE BREAK 15:30 BLOCK 2: Chair: Denis Querleu (France) Chair: Esra Urkmez (Turkey) 15:31 HOW CAN THE PATIENT EVALUATE QUALITY OF CARE? Denis Querleu (France) 15:50 ENGAGE PERSPECTIVE Birthe Lemley (Denmark)

3 16:00 NEW TREATMENT OPTIONS IN OVARIAN CANCER Mansoor Raza Mirza (Denmark) 16:40 RECAP OF THE DAY Esra Urkmez (Turkey) STATE OF THE ART: HOT TOPICS IN FERTILITY SPARING MANAGEMENT 11:00-12:30 HALL A Chair: Philippe Morice (France) Chair: Nicoletta Colombo (Italy) 11:00 FERTILITY SPARING MANAGEMENT IN HIGH RISK EPITHELIAL OVARIAN CANCER Enrica Bentivegna (France) 11:20 CAN WE SAFELY USE OVARIAN HYPERSTIMULATION IN INFERTILE PATIENTS AFTER FSS FOR EPITHELIAL TUMORS? Dominik Denschlag (Germany) 11:40 FERTILITY SPARING MANAGEMENT IN CERVICAL CANCERS BETWEEN 2 AND 4 CM: RADICAL TRACHELECTOMY BY LAPAROTOMY OR NEO- ADJUVANT CHEMOTHERAPY? Ignace Vergote (Belgium) 12:00 HOW LONG SHOULD HORMONAL TREATMENT BE CONTINUED BEFORE DECIDING FOR HYSTERECTOMY IN THE FERTILITY SPARING MANAGEMENT OF ENDOMETRIAL CANCER? Nicoletta Colombo (Italy) 12:20 DISCUSSION PARALLEL: IMAGING IN THE DIAGNOSIS AND MANAGEMENT OF GYNAECOLOGIC CANCER 11:00-12:30 HALL B Chair: Ingfrid Haldorsen (Norway) Chair: Christoph Grimm (Austria) 11:00 ENDOMETRIAL CANCER Ingfrid Haldorsen (Norway) 11:20 CERVICAL CANCER Daniela Fischerova, Ph.D. (Czech Republic) 11:40 OVARIAN CANCER Christoph Grimm (Austria) 12:00 VULVA CANCER Ate Van der Zee (The Netherlands)

4 12:20 DISCUSSION PARALLEL: HPV - PREVENTION AND THERAPY 11:00-12:30 HALL C Chair: Murat Gultekin (Turkey) Chair: Elmar Joura (Austria) 11:00 PROPHYLACTIC AND THERAPEUTIC HPV VACCINATION: STATE OF THE ART Elmar Joura (Austria) 11:20 HPV VACCINATION -THE UK EXPERIENCE David Mesher (United Kingdom) 11:40 HPV PRIMARY SCREENING : IMPLEMENTATION OF THE FIRST NATIONAL PROGRAM WORLDWIDE Murat Gultekin (Turkey) 12:00 COMPREHENSIVE HPV- CANCER PREVENTION OF THE FUTURE Xavier Bosch (Spain) 12:20 DISCUSSION WORKSHOP/SEMINAR: BASIC PRINCIPLES OF RECONSTRUCTION AFTER RADICAL PELVIC SURGERY: A PRACTICAL WORKSHOP 11:00-12:30 HALL M Chair: Gwenaël Ferron (France) Chair: Luis Chiva (Spain) 11:00 TIPS AND TRICKS FOR A SAFE CLOSURE AND RECONSTRUCTION OF THE ABDOMINAL WALL Miguel Angel Garcia-Urena (Spain) 11:20 HOW TO SAFELY REBUILD THE URINARY TRACT Luis Chiva (Spain) 11:40 RECONSTRUCTIVE TECHNIQUES FOR VAGINAL AND PERINEAL DEFECTS Gwenaël Ferron (France) 12:00 BASIC PRINCIPLES OF BOWEL RECONSTRUCTION Roberto Biffi (Italy) 12:20 DISCUSSION

5 ENYGO SESSION: CAREER CORNER - MEET THE PROFESSOR 12:30-14:00 ENYGO LOUNGE:HALL L8 Chair: Kristina Lindemann (Norway) : Rene Laky (Austria) 12:30 CAREER CORNER - MEET THE PROFESSOR'S Denis Querleu (France) 12:30 CAREER CORNER - MEET THE PROFESSOR'S Nadeem Abu Rustum (USA) 12:30 CAREER CORNER - MEET THE PROFESSOR'S Neville Hacker (Australia) INDUSTRY SESSION : SATELLITE SYMPOSIUM 1 13:00-14:30 HALL B ORAL COMMUNICATION: BEST ORAL PRESENTATIONS 02 14:30-15:30 HALL A Chair: Christian Marth (Austria) Chair: Philippe Morice (France) 14:30 PRE-SURGICAL METFORMIN IN UTERINE MALIGNANCY-RESULTS OF THE PREMIUM RANDOMISED CONTROLLED TRIAL : Sarah Kitson (United Kingdom) 14:45 THERAPEUTIC HPV VACCINE-IS IT CLINICALLY USEFUL? : Jong Sup Park (Republic of Korea) 15:00 WHAT MODIFIES THE OUTCOME OF RECURRENT GRANULOSA CELL TUMORS OF THE OVARY? : Isabel Carriles (Spain) 15:15 LION LYMPHADENECTOMY IN OVARIAN NEOPLASMS. A PROSPECTIVE RANDOMIZED AGO STUDY GROUP LED GYNECOLOGIC CANCER INTERGROUP TRIAL. : Domenica Lorusso (Italy)

6 STATE OF THE ART: PATHOLOGY - NEW AND UPDATED WHO 2014 CATEGORIES: WHAT THE CLINICIAN NEEDS TO KNOW 14:30-15:30 HALL B Chair: Sigurd Lax (Austria) Chair: Glenn McCluggage (United Kingdom) 14:30 CERVIX, VULVA, VAGINA Glenn McCluggage (United Kingdom) 14:50 OVARY AND FALLOPIAN TUBE Xavier Matias-Guiu (Spain) 15:10 UTERINE CORPUS Sigurd Lax (Austria) DEBATE: INTRAPERITONEAL CHEMOTHERAPY 14:30-15:30 HALL C Chair: Charlie Gourley (United Kingdom) Chair: Andreas Du Bois (Germany) 14:30 PRO SPEAKER Charlie Gourley (United Kingdom) 14:55 CON SPEAKER Ignace Vergote (Belgium) 15:20 DISCUSSION TASK FORCE: GESTATIONAL TROPHOBLASTIC DISEASES: UPDATE ON SURGICAL ISSUES AND EOTTD GUIDELINES 14:30-15:30 HALL M Chair: Francois Golfier (France) Chair: Frederic Goffin (Belgium) 14:30 EOTTD GUIDELINES FOR HYDATIDIFORM MOLES AND GTN Frederic Goffin (Belgium) 14:50 IS THERE A PLACE FOR A SECOND CURETTAGE IN GTD? Nienke Van Trommel (The Netherlands)

7 15:10 HYSTERECTOMY IN GTN: AN EFFICIENT ROLE IN OLDER WOMEN? Francois Golfier (France) PARALLEL: UP-DATE ON SENTINEL LYMPH NODE IN GYNAECOLOGICAL TUMORS 16:00-17:00 HALL A Chair: David Cibula (Czech Republic) Chair: Eric Leblanc (France) 16:00 DEVELOPMENTS IN DETECTION TECHNIQUES Eric Leblanc (France) 16:20 SLN IMPLEMENTATION INTO MANAGEMENT ALGORITHMS Nadeem Abu Rustum (USA) 16:40 QUESTIONS REMAINED TO BE ANSWERED David Cibula (Czech Republic) PARALLEL: MYTHS AND FACTS ABOUT LIQUID BIOPSIES 16:00-17:00 HALL B Chair: Adriaan Vanderstichele (Belgium) Chair: Heidi Fiegl (Austria) 16:00 WHOLE-GENOME SEQUENCING OF CELL-FREE DNA IN GYNAECOLOGICAL CANCERS Adriaan Vanderstichele (Belgium) 16:20 DETECTION OF METHYLATED DNA IN VARIOUS BODY FLUIDS AND THEIR USE AS DIAGNOSTIC, PROGNOSTIC AND PREDICTIVE TOOLS IN GYNAECOLOGICAL CANCERS Heidi Fiegl (Austria) 16:40 CIRCULATING TUMOR CELLS: CHALLENGES & PERSPECTIVES IN GYNAECOLOGICAL CANCERS Catherine Alix-Panabieres (France)

8 ORAL COMMUNICATION: ORAL 01 - OVARIAN 16:00-17:00 HALL C Chair: Alexandra Leary (France) Chair: Paul Sevelda (Austria) 16:00 RANDOMIZED CONTROLLED PHASE III STUDY TO EVALUATE SECONDARY CYTOREDUCTIVE SURGERY IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER - AGO DESKTOP III/ENGOT OV20 : Jalid Sehouli (Germany) 16:10 PATTERNS OF LYMPH NODE METASTASES IN APPARENT STAGE I LOW- GRADE EPITHELIAL OVARIAN CANCER: A MULTICENTER STUDY. : Lucas Minig (Spain) 16:20 MUCINOUS OVARIAN CANCER (MOC) : WHAT IS THE REPRODUCIBILITY OF THE WHO CLASSIFICATION? : Catherine Genestie (France) 16:30 THE ROLE OF THE PERITONEAL CANCER INDEX IN SURGERY FOR ADVANCED OVARIAN CANCER : Mikkel Rosendahl (Denmark) 16:40 THE PERITONEAL CANCER INDEX(PCI): SELTED REGIONS - AND NOT THE TOTAL PCI - ARE PREDICTIVE OF SURVIVAL IN ADVANCED OVARIAN CANCER : Mikkel Rosendahl (Denmark) 16:50 HORMONAL AND FERTILITY OUTCOME AFTER FERTILITY SPARING SURGERY AND CHEMOTHERAPY FOR OVARIAN NEOPLASMS: A RETROSPECTIVE STUDY : Lorenzo Ceppi (Italy)

9 ORAL COMMUNICATION: ORAL 02 - CERVIX 16:00-17:00 HALL M Chair: Alexander Reinthaller (Austria) Chair: Christine Haie-Meder (France) 16:00 DECISIONAL VALUE OF PRETHERAPEUTIC LAPAROSCOPIC EXTRAPERITONEAL ILIO-PARAAORTIC (EL-PALND) VERSUS PET-CT IN LOCALLY ADVANCED CERVICAL CARCINOMAS (LACC) : Eric Leblanc (France) 16:10 NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 2 UNDER ACTIVE SURVEILLANCE A SYSTEMATIC REVIEW AND META-ANALYSIS : Karoliina Tainio (Finland) 16:20 CERVICAL CANCER RELAPSE RATES IN PATIENTS WITH PARA- AORTIC NEGITIVE PET SCANS:A FIVE-YEAR ANALYSIS IN AN IRISH GYNAEONCOLOGY CENTRE : Ann Rowan (Ireland) 16:30 IMPACT OF ADJUVANT HYSTERECTOMY ON PROGNOSIS IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER TREATED WITH DEFINITIVE CONCURRENT CHEMORADIOTHERAPY: A META-ANALYSIS : Seung-Hyuk Shim (Republic of Korea) 16:40 ONCOLOGICAL AND OBSTETRIC OUTCOME OF ABDOMINAL RADICAL TRACHELECTOMY (ART): AN UPDATED SERIES OF CERVICAL CANCER FROM A 13-YEAR EXPERIENCE : Xiaohua Wu (China) 16:50 OUTCOMES OF ROBOTIC RADICAL HYSTERECTOMY FOR CERVICAL CANCER IN COMPARISON TO OPEN AND LAPAROSCOPIC CASES ; A POPULATION BASED STUDY IN THE UNITED STATES : Sabrina Piedimonte (Canada) INDUSTRY SESSION : SATELLITE SYMPOSIUM 2 17:00-18:00 HALL A

10 NETWORKING EVENTS: OPENING CEREMONY (FOLLOWED BY WELCOME RECEPTION IN EXHIBITION) 18:00-18:55 HALL A Chair: Nadia Mader-Mueller (Austria) Chair: David Cibula (Czech Republic) Chair: Heinz Koelbl (Austria) 18:00 WELCOME FROM ESGO PRESIDENT David Cibula (Czech Republic) 18:05 WELCOME FROM CONGRESS PRESIDENT Heinz Koelbl (Austria) 18:10 WELCOME FROM RECTOR OF MEDICAL UNIVERSITY OF VIENNA Marcus Mueller (Austria) 18:15 THE ROLE OF CENTRAL EUROPE IN THE PAST, THE PRESENCE AND THE FUTURE Karl Habsburg (Austria) 18:35 SINFONIA ACADEMICA OFFSITE SESSION: FROM HYSTERIA TO PSYCHO-ONCOLOGY 20:00-22:00 SIG. FREUD MUSEUM Chair: Annette Hasenburg (Germany) 20:00 GUIDED TOUR 20:30 Luzia Travado (Portugal) 20:31 Vesna Kesic (Serbia) 21:15 Elisabeth Andritsch (Austria)

11 Sunday, November 5, 2017 INDUSTRY SESSION : SATELLITE SYMPOSIUM 3 07:30-08:30 HALL M VIDEO SESSION: INNOVATIVE SURGICAL PROCEDURES IN GYNAECOLOGICAL ONCOLOGY 07:30-08:30 HALL B Chair: Francesco Raspagliesi (Italy) Chair: Alexandros Rodolakis (Greece) 07:30 ROBOTIC EXPERT VIDEO Rainer Kimmig (Germany) 07:40 INDOCYANINE-GREEN (ICG) LABELING FOR COMPARTMENT-BASED ROBOTIC RADICAL SURGERY IN EARLY CERVICAL CANCER Carlo Ronsini (Italy) 07:50 LAPAROSCOPIC SURGERY VIDEO Francesco Raspagliesi (Italy) 08:00 UTERINE TRANSPOSITION SURGICAL TECHNIQUE Reitan Ribeiro (Brazil) 08:10 OPEN SURGERY VIDEO Alexandros Rodolakis (Greece) 08:20 SECONDARY DEBULKING SURGERY FOR ISOLATED PARA-AORTIC NODAL RECURRENCE IN OVARIAN CANCER INVOLVING RENAL MOBILIZATION Kazuyoshi Kato (Japan)

12 WORKSHOP: COLPOSCOPY WORKSHOP 07:30-08:30 HALL C Chair: Vesna Kesic (Serbia) Chair: Alexander Reinthaller (Austria) 07:30 QUALITY INDICATORS FOR COLPOSCOPY Elmar Joura (Austria) 07:50 OBJECTIFYING COLPOSCOPIC FINDINGS: CRITERIA AND NEW TECHNOLOGIES Vesna Kesic (Serbia) 08:10 POSITIVE CERVICAL CYTOLOGY AND/OR HIGH RISK HPV INFECTION - COLPOSCOPIC ASSESSMENT AND CLINICAL MANAGEMENT Alexander Reinthaller (Austria)

13 PATIENTS PROGRAM: PATIENTS PROGRAM 2 08:15-13:40 HALL N Chair: Elisabeth Avall-Lundqvist (Sweden) Chair: Dina Kurdiani (Georgia) 08:15 LATE EFFECTS OF TREATMENT INCL. LYMPAEDEMA 08:16 RADIOTHERAPY Alina Sturdza (Austria) 08:34 SURGERY Jalid Sehouli (Germany) 08:52 CHEMOTHERAPY Elisabeth Avall-Lundqvist (Sweden) 09:10 ENGAGE PERSPECTIVES Maria Papageorgiou (Georgia) 09:30 PRESIDENTIAL ADDRESS - MAIN HALL 10:30 COFFEE BREAK 10:40 ROUNDTABLE DISCUSSION - LET THE EXPERT NGOS SPEAK 10:41 TABLE 1 - POLICY ADVOCACY Simona Ene (Romania) 10:41 TABLE 2 - HOW TO GET DRS INVOLVED WITH NGOS - DANCE WITH CANCER SPEAKER TBA TBA () 10:41 TABLE 3 - WORKING WITH ESGO - PRESIDENT ( ) Denis Querleu (France) 10:41 TABLE 3 - WORKING WITH ESGO - VICE PRESIDENT ELECT ( ) Cristiana Sessa (Switzerland) 11:40 FEEDBACK FROM MEMBERS Chair: Esra Urkmez (Turkey) Chair: Murat Gultekin (Turkey) 12:40 ENGAGE GENERAL ASSEMBLY

14 PARALLEL: THE MANAGEMENT OF VULVA CANCER: ESGO GUIDELINES 08:30-09:30 HALL A Chair: Maaike.H.M. Oonk (The Netherlands) Chair: Sven Mahner (Germany) 08:30 DIAGNOSIS, STAGING AND PREOPERATIVE WORKUP Maaike.H.M. Oonk (The Netherlands) 08:50 SURGERY AND ADJUVANT THERAPY IN PRIMARY DISEASE Sven Mahner (Germany) 09:10 TREATMENT OF RECURRENT AND METASTATIC DISEASE Ate Van der Zee (The Netherlands) PARALLEL: MULTIDISCIPLINARY TREATMENT OF GYNE CANCERS IN ADOLESCENTS 08:30-09:30 HALL B Chair: Cristiana Sessa (Switzerland) Chair: Gabriele Calaminus (Germany) 08:30 INTRODUCTION Cristiana Sessa (Switzerland) 08:40 CASE PRESENTATION 1 :STAGE I GRADE 3 IMMATURE TERATOMA Gabriele Calaminus (Germany) 08:50 CASE PRESENTATION 1 :STAGE I GRADE 3 IMMATURE TERATOMA Philippe Morice (France) 09:00 CASE PRESENTATION 2 :SERTOLI LEYDIG CELL TUMOR Dominik Schneider (Germany) 09:10 CASE PRESENTATION 2 :SERTOLI LEYDIG CELL TUMOR Cristiana Sessa (Switzerland) 09:20 SUMMARY AND CONCLUSIONS Gabriele Calaminus (Germany)

15 ORAL COMMUNICATION: ORAL 03 - ENDOMETRIAL 08:30-09:30 HALL C Chair: Alain G. Zeimet (Austria) Chair: Melanie Powell (United Kingdom) 08:30 HOW TO IMPROVE SENTINEL LYMPH NODE MAPPING WITH INDOCYANINE GREEN (ICG) IN ENDOMETRIAL CANCER? : Noémie Body (Canada) 08:40 REFINEMENT OF HIGH-RISK ENDOMETRIAL-CANCER (HR-EC) CLASSIFICATION USING DNA DAMAGE RESPONSE (DDR) BIOMARKERS: A TRANSPORTEC INITIATIVE : Aurélie Auguste (France) 08:50 IMPACT OF CONSERVATIVE MANAGEMENTS IN YOUNG WOMEN WITH GRADE 2 OR 3 ENDOMETRIAL ADENOCARCINOMA CONFINED TO ENDOMETRIUM : Martin Koskas (Belgium) 09:00 ULTRASOUND CHARACTERISTICS OF ENDOMETRIAL CANCER AS DEFINED BY THE INTERNATIONAL ENDOMETRIAL TUMOR ANALYSIS (IETA) CONSENSUS NOMENCLATURE- A PROSPECTIVE MULTICENTER STUDY : Daniela Fischerova, Ph.D. (Czech Republic) 09:10 THE EFFECT OF HYSTERECTOMY ON PELVIC FLOOR SYMPTOMS : Andreas Obermair (Australia) 09:20 FRENCH MULTICENTRIC RANDOMIZED TRIAL EVALUATING SEVERE PERIOPERATIVE MORBIDITY AFTER ROBOT ASSISTED VERSUS CONVENTIONAL LAPAROSCOPY IN GYNECOLOGIC ONCOLOGY: RESULTS OF ROBOGYN TRIAL. : Fabrice Narducci (France) PARALLEL: PHASE I / II TRIALS: THE ENGOT STRATEGY 08:30-09:30 HALL M Chair: Nicole Concin (Austria) Chair: Ignace Vergote (Belgium) 08:30 ENGOT PHASE I /II TRIALS: INTRODUCTION OF THE NEW GROUP Nicole Concin (Austria) 08:50 A NEW CONCEPT OF UMBRELLA PHASE I/II TRIALS Mansoor Raza Mirza (Denmark) 09:10 FUTURE DIRECTIONS OF INTERESTING COMPOUNDS FOR EARLY CLINICAL TESTING Antonio Casado (Spain)

16 PLENARY: PRESIDENTIAL ADDRESS 09:30-10:30 HALL A Chair: Luis Chiva (Spain) 09:30 INTRODUCTION Luis Chiva (Spain) 09:35 ESGO A STORY OF SUCCESS David Cibula (Czech Republic) STATE OF THE ART: NEW ESGO-ESTRO-ESP GUIDELINES ON CERVICAL CANCER MANAGEMENT 11:00-12:30 HALL A Chair: David Cibula (Czech Republic) Chair: Richard Poetter (Austria) Chair: Maria Rosaria Raspollini (Italy) 11:00 SHAPING NEW CLINICAL PRACTICE GUIDELINES David Cibula (Czech Republic) 11:15 PATHOLOGY REPORT Maria Rosaria Raspollini (Italy) 11:30 MANAGEMENT OF EARLY STAGES David Cibula (Czech Republic) 12:00 MANAGEMENT OF ADVANCED STAGES AND RECURRENT DISEASE Richard Poetter (Austria)

17 PARALLEL: NOVEL CONCEPTS OF PERIOPERATIVE MANAGEMENT 11:00-12:30 HALL B Chair: Stephanie Suria (France) Chair: Karl Tamussino (Austria) 11:00 INITIATING ENHANCED RECOVERY: CHALLENGES AND OPPORTUNITIES Lena Wijk (Sweden) 11:22 WHAT S NEW IN ANESTHESIA FOR HIGH-RISK PATIENTS: WHAT SURGEONS NEED TO KNOW Stephanie Suria (France) 11:45 BOWEL PREPARATION AND CARBO LOADING: WHAT IS THE CURRENT EVIDENCE? Chahin Achtari (Switzerland) 12:07 PERIOPERATIVE CARE OF THE ELDERLY PATIENT Karl Tamussino (Austria) PARALLEL: BREAST CANCER: AN UPDATE 11:00-12:30 HALL C Chair: Christine Solbach (Germany) Chair: Edgar Petru (Austria) 11:00 NEOADJUVANT CHEMO- AND ANTIHORMONAL THERAPY: NEW TARGETS, PATHOLOGICAL RESPONSE AND FUTURE PERSPECTIVES Edgar Petru (Austria) 11:22 MAJOR CHANGES IN SURGICAL THERAPY FOR BREAST CANCER Christine Solbach (Germany) 11:45 ADJUVANT SYSTEMIC CHEMOTHERAPY: WHO DOES NOT NEED IT - WHO NEEDS DOSE DENSE THERAPY? Christian Jackisch (Germany) 12:07 ADJUVANT ENDOCRINE THERAPY - THE LONGER THE BETTER? Mitch Dowsett (United Kingdom)

18 PARALLEL: YOUNG INVESTIGATORS 11:00-12:30 HALL M Chair: Kamil Zalewski (Poland) Chair: Kristina Lindermann (Norway) 11:00 ACCURACY OF PRE-OPERATIVE GRADING BY PIPELLE ENDOMETRIAL SAMPLING AND DILATATION AND CURETTAGE IN ENDOMETRIAL CANCER : Ho Sze Jacqueline Lee (Hong Kong S.A.R.) 11:08 COMPLIANCE TO ADJUVANT TREATMENT GUIDELINES IN ENDOMETRIAL CANCER: ROOM FOR IMPROVEMENT IN HIGH RISK PATIENTS : Florine Eggink, Drs. (The Netherlands) 11:16 PROTEOMIC PROFILING OF ENDOMETRIOID ENDOMETRIAL CANCER REVEALS DIFFERENTIAL EXPRESSION OF HORMONE RECEPTORS AND MAPK SIGNALING PROTEINS IN OBESE VERSUS NON-OBESE PATIENTS : Karen Klepsland Mauland (Norway) 11:24 VULVAR PAGET DISEASE IN THE NETHERLANDS : Michelle Van der Linden (The Netherlands) 11:32 RISK PREDICTION OF SEVERE POSTOPERATIVE COMPLICATIONS IN PATIENTS UNDERGOING GYNECOLOGIC CANCER SURGERY: RESULTS OF A PROSPECTIVE STUDY IN 237 PATIENTS : Gülhan Inci (Germany) 11:40 CLINICAL CHARACTERISTICS AND GENOMIC BIOMARKERS OF THE HOMOLOGOUS RECOMBINATION DEFICIENCY PHENOTYPE IN HIGH-GRADE SEROUS OVARIAN CANCER : Katrien Nulens (Belgium) 11:48 RELIABILITY OF SLN BIOPSY IN PATIENTS WITH BULKY CERVICAL CANCER : Lukas Dostalek (Czech Republic) 11:56 IDENTIFICATION OF PROTEIN MARKERS OF PROGRESSION RISK IN PATIENTS WITH SQUAMOUS CELL VULVAR CARCINOMA : Magdalena Kowalewska (Poland) 12:04 THE ACCURACY OF FROZEN SECTION OF UTERINE LESIONS IN THE PRACTICE OF GYNECOLOGIC SURGERY. A RETROSPECTIVE ASSESSMENT STUDY IN A GOVERNMENT TERTIARY TRAINING HOSPITAL : Jimmy Billod (Philippines) 12:12 ANALYSIS OF PATIENTS WITH CYTOLOGY NEGATIVE AND HPV 16/18 POSITIVE ON CERVICAL CANCER SCREENING PROGRAM: EXPERIENCE FROM A SINGLE CENTER IN EASTERN REGION OF TURKEY : Erbil Karaman (Turkey)

19 12:20 SURGICAL CYTOREDUCTION OF THE UPPER ABDOMEN IN GYNAECOLOGICAL CANCER: AN EXPERIENCE OF ADDITIONAL SKILL ACQUISITION BY THE GYNAECOLOGY ONCOLOGY TEAM FROM COLLABORATION WITH HEPATOBILIARY SURGEONS : Saurabh Phadnis (United Kingdom) ENYGO SESSION: ENYGO/ESGO PROPOSALS FOR TRAINEES 12:30-14:00 ENYGO LOUNGE:HALL L8 Chair: Kamil Zalewski (Poland) Chair: David Lindquist (Sweden) 12:30 ENYGO/ESGO PROPOSALS FOR TRAINEES INDUSTRY SESSION : SATELLITE SYMPOSIUM 3 13:00-14:30 HALL A

20 STATE OF THE ART: ENDOMETRIAL CANCER 14:30-15:30 HALL A Chair: Carien Creutzberg (The Netherlands) Chair: Frederic Goffin (Belgium) 14:30 DIAGNOSTIC AND SURGICAL MANAGEMENT Frederic Goffin (Belgium) 14:50 ADJUVANT TREATMENT Carien Creutzberg (The Netherlands) 15:10 TREATMENT OF ADVANCED DISEASE, INCLUDING MANAGEMENT OF MORBIDITY Alexandra Taylor (United Kingdom) PARALLEL: SEXUAL HEALTH AFTER CANCER DIAGNOSIS AND FOLLOWING TREATMENT 14:30-15:30 HALL B Chair: Kathrin Kirchheiner (Austria) Chair: Diethelm Wallwiener (Germany) 14:30 SEXUAL HEALTH IN GYNAECOLOGIC CANCER PATIENTS - PSYCHO- SOCIAL CONSEQUENCES OF DIAGNOSIS AND TREATMENT Moniek M Ter Kuile (The Netherlands) 14:50 PHYSICAL CONSEQUENCES OF GYNAECOLOGIC CANCER SURGERY AND THEIR IMPACT ON SEXUAL HEALTH Michal Zikan (Czech Republic) 15:10 IMPACT OF VAGINAL MORBIDITY ON SEXUALITY AFTER DEFINITIVE RADIOCHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER PATIENTS Kathrin Kirchheiner (Austria)

21 TASK FORCE: ENGAGE: A COLLABORATION BETWEEN PATIENT ADVOCACY GROUPS AND ESGO 14:30-15:30 HALL C Chair: Murat Gultekin (Turkey) Chair: Esra Urkmez (Turkey) 14:30 POWER OF BEING VISIBLE: MEDIA, NGOS AND AWARENESS ACTIVITIES Murat Gultekin (Turkey) 14:35 THE OTHER SIDE OF THE COIN: PATIENT STORIES INCLUDING LADY GANGA STORY Esra Urkmez (Turkey) 15:00 THE OTHER SIDE OF THE COIN: WHAT THE PATIENTS WANT TO TELL TO THEIR DOCTOR RESULT FROM A SURVEY, INTERACTIVE Esra Urkmez (Turkey) 15:20 HOW CAN THE PATIENTS EVALUATE THE QUALITY OF CARE Denis Querleu (France)

22 ORAL COMMUNICATION: ORAL 04 - OVARIAN II 14:30-15:30 HALL M Chair: Annamaria Ferrero (Italy) Chair: Christoph Grimm (Austria) 14:30 PERIOPERATIVE POSITIONING MANAGEMENT IN GYNECOLOGIC CANCER SURGERY: A NATIONAL NOGGO-AGO INTERGROUP SURVEY : Jenny Katharina Wagner (Germany) 14:40 WHAT ARE THE EXPECTATIONS AND PREFERENCES OF PATIENTS WITH OVARIAN CANCER TO A MAINTENANCE THERAPY? A NOGGO/ENGOT-OV22 SURVEY (EXPRESSION IV) IN 2101 PATIENTS : Irena Rohr (Germany) 14:50 ADVERSE EVENTS AFTER HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) FOR STAGE III OVARIAN CANCER: PHASE III OVHIPEC STUDY : Simone Koole (The Netherlands) 15:00 IDENTIFICATION OF HIGHLY DIFFERENTIALLY EXPRESSED GENES IN PRIMARY OVARIAN CANCER AND RELATED DISTANT METASTASIS USING RNA SEQUENCING : Hanna Sallinen (Finland) 15:10 INTERVAL BETWEEN CYTOREDUCTIVE SURGERY AND ADJUVANT CHEMOTHERAPY IS ASSOCIATED WITH OVERALL SURVIVAL IN PATIENTS WITH ADVANCED OVARIAN CANCER : Maite Timmermans, MD (The Netherlands) 15:20 PALB2 MUTATIONS IN HIGH-RISK WOMEN WITH OVARIAN OR BREAST CANCER : Kelly Metcalfe (Canada) INDUSTRY SESSION : SATELLITE SYMPOSIUM 4 16:00-17:00 HALL A INDUSTRY SESSION : SATELLITE SYMPOSIUM 5 16:00-17:00 HALL B

23 PARALLEL: FUTURE BRACHYTHERAPY CHALLENGES IN THE MANAGEMENT OF ADVANCED CERVICAL CANCER 17:00-18:00 HALL A Chair: Jacob Lindegaard (Denmark) Chair: Akila Viswanathan (India) Chair: Christine Haie-Meder (France) 17:00 CURRENT STATUS OF IMAGE-GUIDED BRACHYTHERAPY : ONCOLOGICAL RESULTS AND COMPLICATIONS Jacob Lindegaard (Denmark) 17:20 IMAGE-GUIDED ADAPTIVE BRACHYTHERAPY VERSUS IMRT/STEREOTACTIC RADIOTHERAPY Akila Viswanathan (India) 17:40 GENERAL IMPLEMENTATION OF IGABT (TRAINING/ MEANS/HEALTH ECONOMICS/RESOURCE LIMITATIONS) Christine Haie-Meder (France) PARALLEL: WHEN, WHY AND HOW TO TEST MOLECULAR BIOMARKERS IN ENDOMETRIAL CANCER 17:00-18:00 HALL B Chair: Alain G. Zeimet (Austria) Chair: Tjalling Bosse (The Netherlands) 17:00 WHEN, WHY AND HOW TO TEST POLE MUTATIONAL STATUS IN ENDOMETRIAL CANCER David Church (United Kingdom) 17:20 WHEN, WHY AND HOW TO TEST FOR L1CAM AND P53 EXPRESSION IN ENDOMETRIAL CANCER Alain G. Zeimet (Austria) 17:40 WHEN, WHY AND HOW TO TEST MISMATCH REPAIR DEFICIENCY IN ENDOMETRIAL CANCER Tjalling Bosse (The Netherlands)

24 ORAL COMMUNICATION: ORAL 05 - VAGINAL AND VULVAR CANCER 17:00-18:00 HALL C Chair: Maaike.H.M. Oonk (The Netherlands) Chair: Sven Mahner (Germany) 17:00 PROGNOSTIC VALUE OF LYMPH NODE RATIO AND NUMBER OF POSITIVE INGUINAL NODES IN PATIENTS WITH VULVAR CANCER : Richard Schwameis (Austria) 17:10 PROGNOSTIC FACTORS FOR LOCAL RECURRENCE OF SQUAMOUS CELL CARCINOMA OF THE VULVA: A SYSTEMATIC REVIEW : Nienke Te Grootenhuis (The Netherlands) 17:20 VULVAR CANCER IN IRELAND: ANALYSIS OF THE IRISH NATIONAL CANCER REGISTRY OVER A 20 YEAR PERIOD : Ann Rowan (Ireland) 17:30 VULVAR CARCINOMA IN NORWAY: A 50-YEAR PERSPECTIVE ON TRENDS IN INCIDENCE, TREATMENT AND SURVIVAL : Christin Julia Meltzer-Gunnes (Norway) 17:40 EXPERIENCE IN INTRODUCING SENTINEL LYMPH NODE BIOPSY IN EARLY- STAGE VULVA CANCER: A SINGLE INSTITUTION BASED PROSPECTIVE STUDY : Ligita Paskeviciute Frøding (Denmark) 17:50 INCIDENCE OF SHORT AND LONG-TERM POSTOPERATIVE MORBIDITY RELATED TO LYMPH NODE DISSECTION FOR VULVAR CANCER : Ellen Barlow (Australia)

25 AFFILIATED: IPOS-ESGO: BODY AND SOUL 17:00-18:30 HALL M Chair: Vesna Kesic (Serbia) 17:00 NEUROCOGNITIVE DYSFUNCTION AFTER CHEMOTHERAPY: PREVALENCE AND TREATMENT (IPOS) Joachim Weis (Germany) 17:22 CHALLENGES FOR PREGNANT WOMEN DIAGNOSED WITH CANCER (ESGO) Tineke Vandenbroucke (Belgium) 17:44 WHY DOES PSYCHOSOCIAL CARE MATTER FOR CANCER PATIENTS? (IPOS) Luzia Travado (Portugal) 18:06 LIFE AFTER CANCER - THE NEW ME (ESGO) Annette Hasenburg (Germany)

26 Monday, November 6, 2017 PARALLEL: PLATINUM RESISTANCE: A CHALLENGE IN OVARIAN CANCER TREATMENT 07:30-08:30 HALL B Chair: Mansoor Raza Mirza (Denmark) Chair: Nicole Concin (Austria) 07:30 PLATINUM-RESISTANT DISEASE: CURRENT STATUS Nicole Concin (Austria) 07:50 STRATEGIES FOR OVERCOMING RESISTANCE TO CHEMOTHERAPY Sandro Pignata (Italy) 08:10 CLINICAL TRIALS IN PLATINUM-RESISTANT DISEASE Mansoor Raza Mirza (Denmark) VIDEO SESSION: SURGERY OF OVARIAN CANCER 07:30-08:30 HALL C Chair: Rene Laky (Austria) Chair: Jordi Ponce (Spain) 07:30 STANDARD SURGICAL STAGING OF EARLY OVARIAN CANCER Jordi Ponce (Spain) 07:50 ADVANCED OVARIAN CANCER: PELVIC CYTOREDUCTION Rene Laky (Austria) 08:10 ADVANCED OVARIAN CANCER: UPPER ABDOMINAL AND EXTENDED CYTOREDUCTION Cagatay Taskeran (Turkey)

27 PARALLEL: TARGETED THERAPIES FOR BRCA1/2 MUTATED TUMORS 08:30-09:30 HALL A Chair: Cristiana Sessa (Switzerland) Chair: Iain McNeish (United Kingdom) 08:30 UPDATE ON THE CLINICAL DEVELOPMENT OF PARP INHIBITORS Iain McNeish (United Kingdom) 08:50 CLINICAL DEVELOPMENT OF OTHER NON PARP TARGETED THERAPIES Cristiana Sessa (Switzerland) 09:10 MECHANISMS OF RESISTANCE IN BRCA MUTATED TUMORS Clare Scott (Australia) ORAL COMMUNICATION: LBO1 08:30-09:30 HALL B TASK FORCE: RARE TUMORS 08:30-09:30 HALL C Chair: Isabelle Ray-Coquard (France) Chair: Jonathan Ledermann (United Kingdom) 08:30 PLACE OF SURGERY FOR RELAPSED GERM CELL TUMORS? Nicoletta Colombo (Italy) 08:45 CONSERVATIVE SURGERY FOR OVARIAN SMALL CELL CARCINOMA, A PLACE? Philippe Morice (France) 09:00 SYSTEMATIC TREATMENT FOR NON-EPITHELIAL TUMOR Isabelle Ray-Coquard (France) 09:15 SYSTEMATIC TREATMENT FOR EPITHELIAL RARE TUMORS Jonathan Ledermann (United Kingdom)

28 ORAL COMMUNICATION: ORAL 06 - PREVENTION, DIAGNOSTICS AND PREINVASIVE DISEASE 08:30-09:30 HALL D Chair: Karl Tamussino (Austria) Chair: Dimitrios Haidopoulos (Greece) 08:30 STATHMIN, A PREDICTIVE BIOMARKER FOR TAXANE RESPONSE IN BREAST CANCER? : Henrica Werner (Norway) 08:40 MRI-BASED PREDICTIVE FACTORS OF AXILLARY LYMPH NODE METASTASES IN BREAST CANCER : David Atallah (Lebanon) 08:50 CLINICAL CHARACTERISTICS AND PROGNOSIS OF ULTRA HIGH- RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA PATIENTS: A RETROSPECTIVE COHORT STUDY : Yujia Kong (China) 09:00 PATTERNS OF CARE AND THE SURVIVAL OF ELDERLY PATIENTS WITH HIGH-RISK ENDOMETRIAL CANCER: A CASE-CONTROL STUDY FROM THE FRANCOGYN GROUP : Vincent Lavoue, MD, PhD (France) 09:10 POTENTIAL CLINICAL IMPACT OF THE INTRODUCTION OF THE NONAVALENT HUMAN PAPILLOMAVIRUS VACCINATION: AN ANALYSIS OF 13,665 PATIENTS OVER A 18-YEAR STUDY PERIOD : Giorgio Bogani (Italy) 09:20 IMPLEMENTATION OF AN ENHANCED RECOVERY AFTER SURGERY (ERAS) PROGRAM: THE MD ANDERSON CANCER CENTER EXPERIENCE : Pedro Ramirez (USA) PLENARY: KEYNOTE LECTURE 1 - RANKL BONES, SEX, AND BREAST CANCER 09:30-10:00 HALL A RANKL -BONES, SEX, AND BREAST CANCER Josef Penninger (Austria)

29 PLENARY: KEYNOTE LECTURE 2 -WHY ARE WE FAILING TO CURE OVARIAN CANCER? 10:00-10:30 HALL A WHY ARE WE FAILING TO CURE OVARIAN CANCER?" Christian Marth (Austria) STATE OF THE ART: ENDOMETRIAL CANCER IN YOUNG WOMEN: NEW CHALLENGES 11:00-12:30 HALL A Chair: Vesna Kesic (Serbia) Chair: Dimitrios Haidopoulos (Greece) 11:00 RISK FACTORS AND PATHOGENESIS OF ENDOMETRIAL CANCER IN YOUNG WOMEN Vesna Kesic (Serbia) 11:20 RADICAL TREATMENT OF ENDOMETRIAL CANCER IN YOUNG WOMEN Nicoletta Colombo (Italy) 11:40 CONSERVATIVE TREATMENT OF ENDOMETRIAL CANCER IN YOUNG WOMEN Dimitrios Haidopoulos (Greece) 12:00 MANAGEMENT OF RECURRENT DISEASE Frederic Amant (The Netherlands) 12:20 DISCUSSION

30 PARALLEL: CURRENT STATUS OF IMMUNOTHERAPY 11:00-12:30 HALL B Chair: Jonathan Ledermann (United Kingdom) Chair: Christian Marth (Austria) 11:00 PRINCIPLES OF IMMUNOTHERAPY Christian Marth (Austria) 11:20 CHALLENGES OF IMMUNOTHERAPY: PREDICTIVE FACTORS AND RESPONSE CRITERIA Francis Balkwill (United Kingdom) 11:40 OVARIAN CANCER IMMUNOTHERAPY TRIALS Jonathan Ledermann (United Kingdom) 12:00 CERVICAL CANCER IMMUNOTHERAPY TRIAL Hans Nijman (The Netherlands) 12:20 DISCUSSION

31 DEBATE: DEBATES ON HOT TOPICS IN CERVICAL CANCER SURGERY 11:00-12:30 HALL C Chair: Denis Querleu (France) Chair: Nadeem Abu Rustum (USA) Chair: Neville Hacker (Australia) 11:00 RADICAL VAGINAL SURGERY, MUSEUM OR OPERATING ROOM? 11:01 ABDOMINAL Nadeem Abu Rustum (USA) 11:10 VAGINAL Patrice Mathevet (France) 11:20 DISCUSSION 11:30 TMMR, THEORY OR PRACTICE? 11:31 PRO Rainer Kimmig (Germany) 11:40 CON David Cibula (Czech Republic) 11:50 DISCUSSION 12:00 NERVE SPARING TECHNIQUES,: ROUTINE OR TAILORED? 12:01 ROUTINE Francesco Raspagliesi (Italy) 12:10 TAILORED Eric Leblanc (France) 12:20 DISCUSSION

32 PARALLEL: PHARMACO ECONOMICS : COST BENEFIT OF MODERN TREATMENT 11:00-12:30 HALL M Chair: Heinz Koelbl (Austria) Chair: Richard Sullivan (United Kingdom) 11:00 HOW CAN EMERGING ECONOMIES DELIVER AFFORDABLE AND EQUITABLE CANCER CARE FOR WOMEN? Richard Sullivan (United Kingdom) 11:20 Bengt Jonsson (Sweden) 11:40 ECONOMIC IMPACT AND REIMBURSEMENT OF DEBULKING SURGERY Heinz Koelbl (Austria) 12:00 COST-EFFICIENCY OF ROBOTIC COMPARED TO LAPAROROSCOPIC APPROACHES IN GYNECOLOGIC ONCOLOGY Jordi Ponce (Spain) 12:20 DISCUSSION ENYGO SESSION: MY MISTAKE:REFELCTIONS ON HADLING A MEDICAL MISTAKE 12:30-14:00 ENYGO LOUNGE:HALL L8 Chair: Stephan Polterauer (Austria) 12:30 MY MISTAKE' REFLECTIONS ON HANDLING A MEDICAL MISTAKE Andreas Obermair (Australia) INDUSTRY SESSION : SATELLITE SYMPOSIUM 7 13:00-14:30 HALL B

33 MEETING: ESGO BUSINESS MEETING 13:00-14:00 HALL M STATE OF THE ART: RECENT HIGHLIGHTS ON OVARIAN CANCER 14:30-15:30 HALL A Chair: Sandro Pignata (Italy) Chair: Jonathan Ledermann (United Kingdom) 14:30 BRCA/HRD Jonathan Ledermann (United Kingdom) 14:50 ANGIOGENESIS Sandro Pignata (Italy) 15:10 HOW TO ASSESS RESECTABILITY AT PRIMARY SURGERY? Anna Fagotti (Italy) PARALLEL: NEW END POINTS TO ASSESS THE IMPACT OF TREATMENT AND RELATED MORBIDITY ON OUTCOME 14:30-15:30 HALL B Chair: Remi Nout (The Netherlands) Chair: Lonneke Van de Poll-Franse (The Netherlands) 14:30 OVERVIEW OF CURRENT DEVELOPMENTS IN MEASURING AND REPORTING PATIENT REPORTED OUTCOMES AND QUALITY OF LIFE IN GYNAECOLOGICAL CANCER Lonneke Van de Poll-Franse (The Netherlands) 14:50 HOW TO INTEGRATE PATIENT REPORTED OUTCOME TOOLS IN THE EVERYDAY GYNAECOLOGICAL CANCER CLINIC Galina Velikova (United Kingdom) 15:10 WHICH ROLE CAN PATIENT REPORTED OUTCOMES AND QUALITY OF LIFE HAVE IN CLINICAL TRIALS Remi Nout (The Netherlands)

34 ORAL COMMUNICATION: ORAL 07 - DIAGNOSTICS AND PREVENTION 14:30-15:30 HALL C Chair: Pauline Wimberger (Germany) Chair: Stephan Polterauer (Austria) 14:30 LONG TERM RESULTS FROM RT3VIN: A MULTI-CENTRE, RANDOMISED, PHASE II TRIAL OF CIDOFOVIR OR IMIQUIMOD TREATMENT FOR VULVAL INTRAEPITHELIAL NEOPLASIA 3 : Sadie Jones (United Kingdom) 14:40 THE ANALGESIC EFFICACY OF FORCED COUGHING DURING CERVICAL PUNCH BIOPSY: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY : Yakir Segev (Israel) 14:50 SENSITIVITY OF NON-INVASIVE PRENATAL FOR CANCER DETECTION AND TREATMENT MONITORING IN PREGNANT WOMEN : Liesbeth Lenaerts, Ir, PhD (Belgium) 15:00 LONG-LASTING INCREASED RISK OF HPV-RELATED CARCINOMAS AND PREMALIGNANCIES AFTER CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 3: A POPULATION-BASED COHORT STUDY : Renee Ebisch (The Netherlands) 15:10 CARDIOVASCULAR RISK AFTER RISK-REDUCING SALPINGO- OOPHORECTOMY IN BRCA1/2 MUTATION CARRIERS: CARSOBRA STUDY : Marieke Arts-de Jong (The Netherlands) 15:20 LONG-TERM EFFICACY AND IMMUNOGENICITY OF THE 9-VALENT HUMAN PAPILLOMAVIRUS VACCINE: FINAL ANALYSES OF A DOUBLE-BLIND, RANDOMIZED CLINICAL STUDY : Elmar Joura (Austria)

35 TASK FORCE: ENITEC AS A FACILITATOR OF ENDOMETRIAL CANCER RESEARCH 14:30-15:30 HALL M Chair: Frederic Amant (The Netherlands) Chair: Henrica Werner (Norway) 14:30 CURETTAGE SPECIMEN GENOTYPING IDENTIFIES HIGH-RISK PATIENTS IN ENDOMETRIAL CANCER Henrica Werner (Norway) 14:45 PROGNOSTIC MARKERS INCLUDING L1CAM EXPRESSION IN ENDOMETRIAL CARCINOMAS: AN ENITEC COLLABORATION STUDY Johanna Pijnenborg (The Netherlands) 15:00 REFINING THE TCGA CLASSIFICATION OF ENDOMETRIAL CANCER Tjalling Bosse (The Netherlands) 15:15 DISCUSSION : TBC TBC () INDUSTRY SESSION : SATELLITE SYMPOSIUM 8 16:00-17:00 HALL B INDUSTRY SESSION : SATELLITE SYMPOSIUM 8 16:00-17:00 HALL C

36 PARALLEL: HEREDITARY BREAST, OVARIAN & UTERINE CANCER 17:00-18:00 HALL A Chair: Pauline Wimberger (Germany) Chair: Uzi Beller (Israel) 17:00 CURRENT CLINICALLY MEANINGFUL ASPECTS AND IMPORTANCE OF GERMLINE AND SOMATIC MUTATIONS IN HEREDITARY BREAST CANCER Jan Lubinski (Poland) 17:20 CURRENT CLINICALLY MEANINGFUL ASPECTS AND IMPORTANCE OF GERMLINE AND SOMATIC MUTATIONS IN HEREDITARY OVARIAN CANCER Pauline Wimberger (Germany) 17:40 CURRENT CLINICALLY MEANINGFUL ASPECTS IN HEREDITARY UTERINE CANCER INCLUDING LYNCH SYNDROME Uzi Beller (Israel) PARALLEL: FUTURE DEVELOPMENT IN CLINICAL TRIALS 17:00-18:00 HALL B Chair: Andreas Du Bois (Germany) Chair: Andres Poveda (Spain) 17:00 SURGICAL TRAILS Andreas Du Bois (Germany) 17:20 THE PARP-I STORY Andres Poveda (Spain) 17:40 THE IMMUNOTHERAPY STORY Lana Kandalaft (Switzerland)

37 AFFILIATED: ESP ESGO:CERVICAL PRECANCER: POST-TREATMENT DISEASE 17:00-18:00 HALL C Chair: Vesna Kesic (Serbia) Chair: Maria Rosaria Raspollini (Italy) 17:00 INTRODUCTION: RISK FACTORS FOR POST-TREATMENT DISEASE Vesna Kesic (Serbia) 17:00 INTRODUCTION: RISK FACTORS FOR POST-TREATMENT DISEASE Maria Rosaria Raspollini (Italy) 17:06 ESGO CLINICIAN: CLINICAL SIGNIFICANCE OF THE MARGINAL STATUS OF THE EXCISED CONE: EFC QUALITY INDICATORS FOR COLPOSCOPY Charles Redman (United Kingdom) 17:24 GUIDELINE ON HOW TO ASSESS THE CONE EXCISED TO TREAT CERVICAL PRECANCER: WHAT NEEDS TO BE UPDATED IN EUROPEAN GUIDELINES ON MANAGEMENT OF CERVICAL LESIONS Sigurd Lax (Austria) 17:42 ESGO CLINICIAN IMPACT OF EXCISIONAL TREATMENT OF CERVICAL PRECANCER ON FERTILITY: A BALANCE BETWEEN ONCOLOGICAL EFFECTIVENESS AND OBSTETRICAL SAFETY Maria Kyrgiou (United Kingdom)

38 ORAL COMMUNICATION: ORAL 08 - QUALITY OF LIFE 17:00-18:00 HALL M Chair: Elisabeth Avall-Lundqvist (Sweden) Chair: Kathrin Kirchheiner (Austria) 17:00 DEVELOPMENT AND PRE-TESTING OF THE EORTC QUALITY OF LIFE QUESTIONNAIRE FOR VULVA CANCER PATIENTS THE SIGNIFICANCE OF PATIENT INVOLVEMENT : Pernille Jensen, Senior Consultant (Denmark) 17:10 PREDICTION MODEL FOR 30-DAY MORBIDITY AFTER GYNECOLOGICAL MALIGNANCY SURGERY : Su hyun Chae (Republic of Korea) 17:20 ASSESSING PATIENT REPORTED QUALITY OF LIFE OUTCOMES IN VULVA CANCER PATIENTS A SYSTEMATIC LITERATURE REVIEW : Ligita Paskeviciute Frøding (Denmark) 17:30 PROSPECTIVE CLINICAL COHORT STUDY FOR EFFICACY ASSESSMENT OF TOPICAL TREATMENT WITH OLIVOLEINA ON POST-SURGICAL SCARS IN PATIENTS UNDERGOING RADIOTHERAPY FOR GYNEACOLOGIC CANCERS : Jesús Molero Vílchez (Spain) 17:40 THE ASSOCIATION OF LYMPHEDEMA TRAJECTORIES WITH SYMPTOMS AND SYMPTOM SEVERITY FOLLOWING GYNAECOLOGICAL CANCER TREATMENT IN QUEENSLAND: A PROSPECTIVE COHORT STUDY : Andreas Obermair (Australia) 17:50 THE NEW NOMAL; SEXUAL FUNCTION AFTER OVARIAN CANCER FOR SURVIVORS AND PARTNERS COMPARED TO NORMDATA : M.Caroline Vos, MSc (The Netherlands)

39 TUMOR BOARD: TUMOR BOARD: OVARIAN CANCER 18:00-19:00 HALL A Chair: Philipp Harter (Germany) Chair: Cristiana Sessa (Switzerland) 18:00 SURGICAL MANAGEMENT IN PRIMARY OVARIAN CANCER Giovanni Aletti (Italy) 18:15 RECURRENT OVARIAN CANCER - ROLE OF SURGERY Philipp Harter (Germany) 18:30 PLATINUM ELIGIBLE RECURRENT OVARIAN CANCER Cristiana Sessa (Switzerland) 18:45 DISCUSSION TUMOR BOARD: TUMOR BOARD CERVICAL CANCER: EARLY STAGE POSITIVE NODES 18:00-19:00 HALL B Chair: Remi Nout (The Netherlands) Chair: Alexander Reinthaller (Austria) 18:00 CERVICAL CANCER STAGE IB1, 3CM TUMOR DIAMETER: EVALUATION OF LYMPH NODES, RISK FACTORS AND THERAPEUTIC MANAGEMENT Remi Nout (The Netherlands) 18:20 CERVICAL CANCER IB1, 2CM TUMOR DIAMETER: SLN BIOPSY, MANAGEMENT IN REGARD TO ABSENCE/PRESENCE OF METASTATIC DISEASE Alexander Reinthaller (Austria) 18:40 CERVICAL ADENOCARCINOMA IB1 AFTER RADICAL HYSTERECTOMY, POSITIVE LYMPHNODES - EVALUATION OF PERIAORTIC NODES, ADJUVANT THERAPY, MANAGEMENT OF OVARIES Sebastien Gouy (France)

40 TUMOR BOARD: TUMOR BOARD ENDOMETRIAL CANCER: ADVANCED STAGE 18:00-19:00 HALL C Chair: Melanie Powell (United Kingdom) Chair: Guenter Emons (Germany) 18:00 CASE 1: ADVANCED ENDOMETRIAL CANCER, AMENABLE TO SURGICAL RESECTION, ROLE OF NEOADJUVANT CHEMOTHERAPY Frederic Amant (The Netherlands) 18:20 CASE 2: ADVANCED, METASTATIC, TREATMENT WITH RADIOTHERAPY AND CHEMOTHERAPY Melanie Powell (United Kingdom) 18:40 CASE 3: DISTANT METASTASES, ENDOCRINE THERAPY, CHEMOTHERAPY Guenter Emons (Germany) TUMOR BOARD: TUMOR BOARD: OBESITY 18:00-19:00 HALL M Chair: Andreas Obermair (Australia) Chair: Emma Crosbie (United Kingdom) 18:00 SURGERY (TO DISCUSS RELATIVE MERITS OF ROBOTIC, STRAIGHT STICK LAPAROSCOPY, LAPAROTOMY, VAGINAL HYSTERECTOMY AND HYSTERECTOMY PLUS PANNICULECTOMY/APRONECTOMY, PRE-, INTRA- AND POST-OP CONCERNS INCLUDING ANAESTHETIC ISSUES Jason Wright (USA) 18:15 RADIOTHERAPY (WITH CURATIVE OR PALLIATIVE INTENT, THE CONSIDERATIONS FOR OBESE PATIENTS, MODE OF DELIVERY, CURE RATES) Carien Creutzberg (The Netherlands) 18:30 MIRENA (TO DISCUSS SUCCESS RATES, MIRENA VS MPA, FEMME TRIAL, PROS AND CONS, RELAPSE RATES, PREGNANCY RATES Andreas Obermair (Australia) 18:45 BARIATRIC SURGERY/MIRENA (TO DISCUSS PROS/CONS IN CONTEXT OF TREATMENT OF DISEASE, REDUCING RISK OF RECURRENCE, PREGNANCY RATES, FITNESS FOR HYSTERECTOMY, LONG TERM HEALTH Emma Crosbie (United Kingdom)

41 GLASS WITH EXPERT: GLASS WITH THE EXPERT 18:00-19:00 HALL L3 18:00 MANAGEMENT OF STAGE IB2 CERVICAL CANCER Neville Hacker (Australia) 18:00 MOLECULAR CLASSIFICATIONS OF ENDOMETRIAL CANCERS Tjalling Bosse (The Netherlands) 18:00 HISTOLOGICAL AND MOLECULAR CLASSIFICATION OF EPITHELIAL OVARIAN CANCER Sigurd Lax (Austria) 18:00 SLN ALGORITHM ALONE IN STAGE I CERVICAL CANCER Nadeem Abu Rustum (USA) 18:00 HIPEC IN OVARIAN CANCER Giovanni Scambia (Italy) 18:00 ROBOTIC SURGERY IN GYNAECOLGICAL ONCOLOGY Henrik Falconer (Sweden) 18:00 SURGICAL OR RADIOLOGICAL STAGING OF ADVANCED CERVICAL CANCER Denis Querleu (France) 18:00 ANESTHESIOLOGIC MANAGEMENT AND PERIPERATIVE CARE IN DEBULKING SURGERY FOR OVARIAN CANCER Stephanie Suria (France) 18:00 PREDICTIVE BIOMARKERS OF RESPONSE TO NACT IN OVARIAN CANCER Alexandra Leary (France) 18:00 HOW TO IDENTIFY PATIENTS WHO BENEFIT FROM SURGERY OF RECURRENT OVARIAN CANCER Andreas Du Bois (Germany) 18:00 PERSPECTIVES OF IMMUNOTHERAPY IN CERVICAL CANCER Jonathan Ledermann (United Kingdom) 18:00 HOW TO PLAN BREAST RECONSTRUCTION? Christine Solbach (Germany) 18:00 PREVENTION AND MANAGEMENT OF SIDE-EFFECTS OF RADIOTHERAPY IN GYNAECOLOGIC CANCER Richard Poetter (Austria) 18:00 FSS IN ADVANCED STAGE GERM CELL TUMORS Michael Seckl (United Kingdom) 18:00 CURRENT UPDATE IN THE MANAGEMENT OF SIDE-EFFECTS IN NEOADJUVANT CHEMOTHERAPY Edgar Petru (Austria) 18:00 KEY ISSUES AND PITFALLS OF THE DEBULKING SURGERY IN THE UPPER PART OF THE ABDOMEN Jalid Sehouli (Germany)

42 OFFSITE SESSION: SEXUALITY AND ONCOLOGY 20:00-22:00 SECESSION Chair: Vesna Kesic (Serbia) 20:00 GUIDED TOUR 20:30 A WOMEN S GUIDE TO SEXUALITY WITH AND AFTER CANCER Annette Hasenburg (Germany) 21:15 THE IMPACT OF A GYN CANCER ON THE SEXUAL WELL-BEING OF THE PARTNER Leen Aerts (Belgium)

43 Tuesday, November 7, 2017 PARALLEL: UPDATE ON SUPPORTIVE CARE 07:30-08:30 HALL C Chair: Felix Hilpert (Germany) Chair: Jorn Herrstedt (Denmark) 07:30 PERIOPERATIVE SUPPORTIVE CARE IN GYNECOLOGIC CANCER PATIENTS Felix Hilpert (Germany) 07:50 SUPPORTIVE CARE IN GYNECOLOGIC CANCER PATIENTS RECEIVING MEDICAL TREATMENT Jorn Herrstedt (Denmark) 08:10 SUPPORTIVE CARE FOR WOMEN WITH GYNAECOLOGIC CANCER RECEIVING EXTERNAL BEAM RADIOTHERAPY AND BRACHYTHERAPY Alina Sturdza (Austria)

44 WORKSHOP/SEMINAR: FELLOWS WORKSHOP 08:30-12:00 HALL N 08:30 OVARIAN CANCER 08:30 Chair: Stephan Polterauer (Austria) 08:30 Chair: Vladyslav Sukhin (Ukraine) 08:30 HOW TO SELECT PATIENTS FOR UPFRONT DEBULKING SURGERY (PET VS CT VS DIAGNOSTIC LAPAROSCOPY): PRESENTATION OF DIFFERENT APPROACHES/FEASIBILITY/DISCUSSION. Giovanni Aletti (Italy) 08:50 PARAAORTIC LYMPHADENECTOMY Ignacio Zapardiel Gultierrez (Spain) 09:00 PELVIC LYMPHADENECTOMY Michael Halaska (Czech Republic) 09:10 EXTRAPERITONEAL EN BLOC HYSTERECTOMY/OOPHORECTOMY/COLECTOMY Rene Laky (Austria) 09:25 EN BLOC SPLENECTOMY/OMENTECTOMY Giovanni Aletti (Italy) 09:40 DIAPHRAGM RESECTION (SANDWICH TECHNIQUE) Christoph Grimm (Austria) 09:50 PODIUMS DISCUSSION 10:30 COFFEE BREAK 11:00 PALLIATIVE CARE 11:00 Chair: David Lindquist (Sweden) 11:00 Chair: Polat Dursun (Turkey) 11:00 MANAGEMENT OF MALIGNANT BOWEL OBSTRUCTION - SURGERY? Thomas Bachleitner (Austria) 11:15 MANAGEMENT OF MALIGNANT BOWEL OBSTRUCTION - CONSERVATIVE TREATMENT? Edgar Petru (Austria) 11:30 PALLIATIVE RADIOTHERAPY - BENEFITS AND LIMITATIONS Carien Creutzberg (The Netherlands) 11:45 PANEL DISCUSSION AND ROOM FOR QUESTIONS

45 PARALLEL: SURVIVORSHIP 07:30-08:30 HALL M Chair: Elisabeth Avall-Lundqvist (Sweden) Chair: Lonneke Van de Poll-Franse (The Netherlands) 07:30 LATE EFFECTS AND LONG TERM COMPLICATIONS OF CANCER THERAPY Elisabeth Avall-Lundqvist (Sweden) 07:50 SYMPTOM MANAGEMENT OF LATE SIDE-EFFECTS AMONG GYNECOLOGICAL CANCER SURVIVORS Heidi Donovan (USA) 08:10 WHAT IS NEEDED IN SURVIVORSHIP CARE Lonneke Van de Poll-Franse (The Netherlands)

46 ORAL COMMUNICATION: ORAL 09 - OVARIAN AND CERVICAL CANCER 08:30-09:30 HALL B Chair: Luis Chiva (Spain) Chair: Jordi Ponce (Spain) 08:30 CONSERVATIVE SURGERY FOR THE TREATMENT OF GRANULOSA CELL TUMORS OF THE OVARY: RESULTS FROM THE MITO 9 STUDY : Alice Bergamini, dr (Italy) 08:40 PRETERM BIRTH AND CONIZATION PRIOR TO PREGNANCY: AN ANALYSIS OF THE NATIONAL INPATIENT QUALITY SURVEY DATA IN GERMANY; : Christian Dannecker (Germany) 08:50 PROVE A PHASE II RANDOMIZED MULTICENTER STUDY OF PANITUMUMAB IN PLATINUM-SENSITIVE EPITHELIAL OVARIAN CANCER PATIENTS WITH KRAS WILD-TYPE : Radoslav Chekerov (Germany) 09:00 EFFECTIVENESS OF NATIONAL HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM FOR JAPANESE YOUNG WOMEN : Yamaguchi Manako (Japan) 09:10 CLINICAL ANALYSIS OF ENDOMETRIOID AND CLEAR CELL CARCINOMA OF THE OVARY WITH OR WITHOUT ENDOMETRIOSIS : Uchul Ju (Republic of Korea) 09:20 COMPARISON OF MRI, PET-CT, AND FROZEN BIOPSY IN THE EVALUATION OF LYMPH NODE STATUS BEFORE FERTILITY-SPRING RADICAL TRACHELECTOMY IN EARLY STAGE CERVICAL CANCER : Jeong-Yeol Park (Republic of Korea) PARALLEL: HISTORY OF GYNAECOLOGICAL ONCOLOGY IN AUSTRIA 08:30-09:30 HALL C Chair: Wolfgang Graninger (Austria) Chair: Karl Tamussino (Austria) 08:30 FROM SEMMELWEIS AND PUERPERAL SEPSIS TO MULTIRESISTANT BACTERIA: A HISTORY OF HOSPITAL INFECTION CONTROL Wolfgang Graninger (Austria) 09:00 LIGHT AND DARKNESS: THE HISTORY OF GYNAE ONCOLOGY IN AUSTRIA Karl Tamussino (Austria)

47 ORAL COMMUNICATION: ORAL 10 - ENDOMETRIAL II 08:30-09:30 HALL M Chair: Daniel Reimer (Austria) Chair: Frederic Goffin (Belgium) 08:30 EXPRESSION OF L1CAM IN CURETTAGE AND HIGH L1CAM LEVEL IN PREOPERATIVE BLOOD SAMPLES PREDICTS LYMPH NODE METASTASES AND POOR OUTCOME IN ENDOMETRIAL CANCER PATIENTS : Ingvild Loberg Tangen (Norway) 08:40 CIRCULATING CELL-FREE DNA IN ENDOMETRIAL CANCER. : Lucia Cicchillitti, Ph.D (Italy) 08:50 PROGNOSTIC BENEFIT OF POLE EXONUCLEASE DOMAIN MUTATIONS IN ENDOMETRIAL CANCER CANNOT BE EXPLAINED BY INCREASED SENSITIVITY TO ADJUVANT TREATMENT STRATEGIES : Inge Van Gool (The Netherlands) 09:00 POST-PREGNANCY OUTCOMES OF YOUNG PATIENTS WITH ENDOMETRIAL CANCER OR ATYPICAL ENDOMETRIAL HYPERPLASIA WHO RECEIVED FERTILITY-PRESERVING HORMONAL THERAPY USING MEDROXYPROGESTERONE ACETATE. : Nobuyuki Susumu (Japan) 09:10 A COMPARATIVE STUDY OF TWO FOLLOW-UP STRATEGIES FOLLOWING TREATMENT OF ENDOMETRIAL CANCER BETWEEN AN ITALIAN AND A UK CENTRE : Valentina Ghirardi (United Kingdom) 09:20 DOES THE NODAL RE-STAGING SURGERY FOR HIGH RISK ENDOMETRIAL CANCER, ACCORDING TO THE RECOMMENDATIONS OF THE ESMO-ESGO-ESTRO GUIDELINES, CHANGE THE MANAGEMENT OF PATIENTS? : Sebastien Gouy (France)

48 PARALLEL: MANAGEMNENT OF GYNAECOLOGICAL CANCERS IN ELDERLY 09:30-10:30 HALL A Chair: Annamaria Ferrero (Italy) Chair: Dina Kurdiani (Georgia) 09:30 FRAILTY EVALUATION AND MEDICAL TREATMENT OF ELDERLY POPULATION WITH GYNAECOLOGICAL MALIGNANCIES Annamaria Ferrero (Italy) 09:50 ELDERLY PATIENTS UNDERGOING SURGERY FOR OVARIAN OR CERVICAL CANCER: PERI-OPERATIVE ASSESSMENT AND SURGICAL CHOICES Dina Kurdiani (Georgia) 10:10 LAPAROSCOPIC VERSUS OPEN TREATMENT OF ENDOMETRIAL CANCER IN ELDERLY WOMEN Ignacio Zapardiel Gultierrez (Spain) PARALLEL: PREDICTIVE MARKERS IN GYNAE CANCERS 09:30-10:30 HALL C Chair: Alexandra Leary (France) Chair: Xavier Matias-Guiu (Spain) 09:30 PREDICTIVE MARKERS IN ENDOMETRIAL CARCINOMA Xavier Matias-Guiu (Spain) 09:50 PREDICTIVE MARKERS IN OVARIAN CARCINOMA Alexandra Leary (France) 10:10 PREDICTIVE MARKERS IN CERVICAL CANCER Tjalling Bosse (The Netherlands)

49 AFFILIATED: ESTRO - STATE OF THE ART TREATMENT OF VAGINAL CANCER 09:30-10:30 HALL M Chair: Remi Nout (The Netherlands) Co-Chair: Richard Poetter (Austria) 09:30 INTRODUCTION AND REVIEW OF TREATMENT FOR VAGINAL CANCER Remi Nout (The Netherlands) 09:50 IMAGE GUIDED RADIOTHERAPY FOR VAGINAL CANCER Maximilian Schmid (Austria) 10:10 RESULTS OF IMAGE GUIDED BRACHYTHERAPY AND FUTURE OUTLOOK Henrike Westerveld (The Netherlands) PARALLEL: FOLLOW-UP OF STATE OF ART MEETING: PREVENTION GYNAECOLOGICAL CANCER, ANTALYA :00-12:30 HALL C Chair: Murat Gultekin (Turkey) Chair: Vesna Kesic (Serbia) 11:00 THE IMPACT OF HEALTHY LIFE STYLE AND OBESITY ON PREVENTION OF GYNAECOLOGICAL CANCERS Maria Kyrgiou (United Kingdom) 11:22 STATE OF ART IN SCREENING OF GYNAECOLOGICAL CANCERS Murat Gultekin (Turkey) 11:45 HEREDITARY GYNAECOLOGICAL CANCERS: PREVENTION AND ROLE OF PROPHYLACTIC SURGERIES Ranjit Manchanda (United Kingdom) 12:07 PSYCHO-SOCIAL ISSUES IN GYNAECOLOGICAL CANCER PREVENTION Vesna Kesic (Serbia)

50 STATE OF THE ART: UPDATES ON RARE GYNAECOLOGICAL CANCERS 11:00-12:30 HALL B Chair: Michael Seckl (United Kingdom) Chair: Isabelle Ray-Coquard (France) 11:00 RECENT DEVELOPMENTS IN GTD AND MOLAR PREGNANCIES Leon Massuger (The Netherlands) 11:22 HOW CAN WE ELIMINATE DEATHS IN HIGH RISK GTN? Michael Seckl (United Kingdom) 11:45 WHAT IS THE STATE-OF-THE-ART FOR OVARIAN GERM CELL TUMOURS? Jalid Sehouli (Germany) 12:07 CURRENT AND FUTURE DIRECTIONS FOR GRANULOSA CELL TUMOUR MANAGEMENT Isabelle Ray-Coquard (France) PLENARY: CLOSING CEREMONY AND AWARDS 12:30-13:00 HALL B Chair: Denis Querleu (France) Chair: Heinz Koelbl (Austria)